Orthopedic & Dental Implants

Orthopedic & Dental Implants Platinum-Cured Liquid Silicone Rubber LSR Injection Molding with Fanuc Roboshot α-SiB 220T

As engineers designing for the human body, we operate in a realm of zero tolerance for failure. The components we create for Orthopedic & Dental Implants are not merely parts in an assembly; they are mission-critical devices that directly impact patient outcomes, mobility, and quality of life. The material and manufacturing choices we make are scrutinized under the harshest regulatory and performance lenses. This is where the conversation transcends simple part production and enters the domain of absolute process control. The challenge is immense: sourcing materials with superior biocompatibility and stability, then processing them with a precision that guarantees the integrity of every single unit, from the first to the millionth.

This technical brief addresses the apex solution for this challenge: the specialized LSR Injection Molding of platinum-cured liquid silicone rubber. Specifically, we will dissect how MechanoFab leverages the unparalleled precision of the Fanuc Roboshot α-SiB 220T to master the notoriously difficult processing of materials like Wacker SILPURAN® 6000/40. The core difficulty with these materials lies in their fundamental properties: an extremely low, water-like viscosity and a sensitive, platinum-catalyzed 1:1 mix ratio curing system. Any minute deviation in pressure, temperature, or mix proportion results in catastrophic failure—incomplete cures, dimensional instability, or catalyst poisoning that compromises biocompatibility. Traditional hydraulic or hybrid molding machines, with their inherent process variability, are simply not equipped for this level of control. They introduce risks that are unacceptable in the medical device space. Our approach is engineered to eliminate these risks at the source.

The Nexus of Process Control and Medical Compliance

Achieving compliance with standards like ISO 13485, FDA Class II/III requirements, and material-specific ASTM norms is not a box-ticking exercise; it's a direct function of your manufacturing process capability. A certificate on the wall is meaningless if the machine on the floor cannot repeatedly and reliably produce parts that meet the validated specification. This is where our selection of the all-electric Fanuc Roboshot platform becomes a cornerstone of our compliance strategy.

ISO 13485: The Mandate for a Robust QMS ISO 13485 is fundamentally about risk management and maintaining a state of control over your entire Quality Management System. For molding, this translates to rigorous process validation (IQ/OQ/PQ) and unwavering shot-to-shot consistency. The Roboshot’s all-electric, closed-loop servo system provides the data and control necessary for a bulletproof validation package. Every parameter—injection speed, pressure, clamp force, screw position, barrel temperature—is digitally controlled and monitored in real-time. This creates an immutable data log for every cycle, providing the traceability required by auditors and the process stability needed to achieve a Cpk well above the 1.33 or 1.66 minimums often demanded for critical dimensions. Unlike hydraulic systems where oil temperature fluctuations can cause significant process drift, the Roboshot’s performance is deterministic. This means that once the process is validated, it stays validated, drastically reducing the risk of non-conformance and ensuring a continuous state of control.

FDA Class II/III: Purity and Part Integrity For high-risk Class II and Class III medical devices, the FDA’s primary concern is patient safety, which hinges on material purity and component integrity. Platinum-cured LSRs like Wacker SILPURAN® 6000/40 are chosen for their inertness and lack of extractables. However, the manufacturing process itself can introduce contaminants or defects. The most common failure point is flash—thin, unwanted excess material that creeps into the parting line of the mold. This is a direct result of imprecise clamp force control or mold-half parallelism. Less advanced machines struggle to manage the ultra-low viscosity of LSR, leading to flash that must be removed in a secondary operation.

This is a critical risk vector. Manual deflashing with a blade introduces bioburden, particulates, and human error, leading to dimensional variance. Cryogenic deflashing, while more controlled, can induce thermal shock, creating micro-cracks that become failure points under fatigue. Our strategy directly mitigates this. The Roboshot’s superior clamp force precision and thermal stability allow us to engineer and execute truly flash-free tooling. We produce net-shape components directly from the press. The part that emerges from the mold is the final, finished part. This single-step strategy eliminates entire categories of risk: no secondary handling, no risk of blade-induced contamination, no chance of cryogenic damage. This is a powerful statement in any FDA submission, demonstrating a process designed from the ground up to ensure part purity and integrity.

ASTM Compliance: From Datasheet to Real-World Performance Material datasheets, governed by standards like ASTM F136/F75 (principles of which apply to material integrity), promise specific physical properties like tensile strength and elongation. However, these properties are only realized if the material is processed perfectly. For a two-part LSR, this means the 1:1 mix ratio must be exact, and the material must not be exposed to contaminants that could poison the platinum catalyst. The Roboshot’s precision dosing system, coupled with its AI-driven injection pressure control, ensures the mix ratio is flawlessly maintained. Furthermore, the machine’s design and our stringent cleanroom protocols prevent exposure to cure-inhibiting substances (like sulfur, tin, or certain amines), guaranteeing that the final molded part exhibits the full mechanical and biocompatible properties specified by the material manufacturer. Your FEA models and performance predictions can be trusted, because the physical part is a true representation of the engineered material.

Core Process & Machine Specifications

The synergy between material, process, and machine is what enables us to deliver components that meet the extreme demands of implantable medical devices. The following table outlines the key parameters that define this capability.

The Economics of Precision: Total Cost of Ownership vs. Part Price

When sourcing high-volume medical components, it's tempting to focus solely on the per-part price. However, for a production scale of 5,000 to 100,000+ units, a sophisticated engineering analysis must prioritize Total Cost of Ownership (TCO). Our manufacturing strategy, built around the Fanuc Roboshot and net-shape tooling, is optimized for the lowest TCO, even if the initial part price is not the absolute lowest on the market. The cost savings are realized by eliminating the significant, often hidden, expenses and risks associated with less precise manufacturing methods.

Let's deconstruct the alternative. A manufacturer using a standard hydraulic press to mold low-viscosity LSR will almost certainly produce parts with flash. This "cheaper" process now necessitates a chain of costly and risky secondary operations.

1. The Cost of Deflashing: The parts must be sent for cryogenic deflashing or be trimmed manually. This is a direct, added cost per unit. Cryogenic processes require specialized equipment and liquid nitrogen, while manual trimming incurs significant labor costs.
2. The Cost of Yield Loss: Cryogenic deflashing is an aggressive process that can make parts brittle, causing micro-cracks or breaking delicate features. Manual trimming is inconsistent. In both cases, a percentage of parts will be damaged and must be scrapped. A 5-10% scrap rate on a "cheaper" part can easily make it more expensive than a higher-quality, net-shape component.
3. The Cost of Inspection: Because the deflashing process introduces defects, your quality protocol must now include 100% visual or automated inspection to find and remove damaged parts. This is another massive labor or capital expense that is completely absent in a net-shape manufacturing workflow.
4. The Cost of Risk: This is the most significant cost. For an orthopedic or dental implant, a component failure can be catastrophic, leading to patient harm, lawsuits, and brand destruction. A micro-crack induced during deflashing is a latent defect waiting to cause a field failure. A loose particulate of silicone left over from trimming can compromise the sterility of the final device. These are not theoretical risks; they are the direct, foreseeable consequences of choosing a manufacturing process that is not fully in control.

Our single-step strategy at MechanoFab annihilates these downstream costs. By investing in the extreme process control of the Roboshot and the precision of flash-free mold design, we produce a component that is finished the moment it ejects from the press. The TCO is dramatically lower because there is no secondary deflashing cost, yield loss is negligible, and the need for intensive post-molding inspection is eliminated. Most importantly, the risk of process-induced failure is engineered out from the very beginning. This is the economic embodiment of designing for manufacturability, and it is the only logical approach for critical medical components at scale.

Conclusion

For engineers developing the next generation of orthopedic and dental implants, component manufacturing cannot be an afterthought. The choice of a manufacturing partner and process is as critical as material selection and part design. By pairing the inherent biocompatibility of platinum-cured LSR with the uncompromising precision of the Fanuc Roboshot α-SiB 220T, we offer more than just a part; we deliver a validated, repeatable, and risk-mitigated manufacturing solution. We provide the process control that ensures your design intent is perfectly translated into a physical component you can trust.